Myricetin and Hesperidin Inhibit Cerebral Thrombogenesis and Atherogenesis in Apoe-/- and Ldlr-/- Mice

Journals Menu

Follow SCIRP

ISSN Print: 2157-944X
ISSN Online: 2157-9458
www.scirp.org/journal/fns
E-mail: fns@scirp.org

"Myricetin and Hesperidin Inhibit Cerebral Thrombogenesis and Atherogenesis in Apoe^-/- and Ldlr^-/- Mice"
written by Yasuto Sasaki, Kanae Hyodo, Ayana Hoshino, Eri Kisa, Koichi Matsuda, Yoko Horikawa, John C. Giddings,
published by Food and Nutrition Sciences, Vol.9 No.1, 2018

has been cited by the following article(s):

[1]	Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders
	CNS & Neurological …, 2024

[2]	Antihypertensive phytocomplexes of proven efficacy and well-established use: Mode of action and individual characterization of the active constituents
	2020

[3]	Antihypertensive phytocomplexes of proven efficacy and weel-established use: mode of action and individual characterization of the active constituents
	…, 2019

[4]	基因敲除动脉粥样硬化小鼠模型研究进展
	研究, 2019

Follow SCIRP